Overview

Implantable Pulse Generator Market Overview:

Implantable pulse generator is a medical device that is battery-powered and when implanted in the body, it electrically stimulates the nervous system so that different nerve impulses in the body are either blocked or stimulated. This technology is a promising treatment for various medical conditions like hypertension, reducing back pain, curing diabetes to stop dosage of insulin taken on a daily basis and obesity. Implantable pulse generator can also be used in cases where medicines are either showing some side effects or are completely ineffective.

Implantable pulse generator is programmed to provide electric stimuli to nervous systems and essential for neuro-modulation. The rapid advancement of technologies integrated the multiple parameters and increased demand among the end user segment. Further, changing life pattern increased the prevalence of chronic disorders and fuelled the growth of the market. Neuromodulation is a novel method of a prosthesis for better management of disease prognosis. They are proven effective and safe compared to the traditional method of treatments. Along with this, growing research initiatives like European human brain project and US brain research activities are expected to advance the neuro-technologies. Further, increasing financial investments by top tier manufacturers led to rapid growth of the market.

North America market is expected to witness high market share in global market due to adoption of Neuromodulation in disease management. It is dominated the US due to strong intensity of top tier manufacturers. It is followed by the European region and it accounts a significant share in the global market due to supportive regulations. Asia-Pacific region is the third major shareholder in the global market due to increasing research activities. Latin America represented a fast growing region in global market due to rising awareness among end-user segment. Rest of World accounts the small fraction of market share due to less adoption.

Implantable Pulse Generator market players include:
• Medtronic, Inc.
• Boston Scientific Corporation
• St. Jude Medical, Inc.
• Synapse Biomedical, Inc.
• Nevro Corporation
• Neurosigma, Inc.
• Neuropace, Inc.
• Cyberonics, Inc.
• BioControl Medical
(Note: The list of the major players will be updated with the latest market scenario and trends)

Implantable Pulse Generator Market Segmentation:

By Product Type
• Implantable cardiac pacemakers
• Implantable defibrillators
• Cochlear implants
• Implantable nerve stimulators (FES)
  o Limb function stimulation
  o Bladder stimulators
  o Sphincter stimulators
  o Diaphragm stimulators
  o Analgesia
• Implantable infusion pumps
• Implantable active monitoring devices

By Application
• Neurovascular Diseases
• Cardiovascular Diseases
• Orthopedic

By End User
• Hospitals
• Ambulatory Surgical Centers
• Home Care Settings
• Clinics

By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Rest of the World

Competitive Landscape:  
•    Tier 1 players- established companies in the market with a major market share
•    Tier 2 players 
•    Emerging players which are growing rapidly 
•    New Entrants  

FutureWise Key Takeaways: 
•    Growth prospects
•    SWOT analysis 
•    Key trends 
•    Key data-points affecting market growth 

Objectives of the Study: 
•    To provide with an exhaustive analysis on the global Implantable Pulse Generator Market By Product Type, By Application, By End User and By Region.
•    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
•    To evaluate and forecast micro-markets and the overall market 
•    To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
•    To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
•    Profiling of companies to evaluate their market shares, strategies, financials and core competencies  

Flexible Delivery Model:

•    We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•    The customization Mobility Care offered are free of charge with purchase of any license of the report
•    You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1. Objectives of the Study 
   1.2. Market Definition 
   1.3. Market Scope 
        1.3.1. Years Considered for the Study
        1.3.2. Market Covered
   1.4. Currency 
   1.5. Limitations 
   1.6. Stakeholders 

2. Research Methodology 
   2.1. Research Data 
        2.1.1. Secondary Data
               2.1.1.1. Key Data from Secondary Sources
        2.1.2. Primary Data
               2.1.2.1. Key Data from Primary Sources
   2.2. Market Size Estimation 
   2.3. Market Breakdown and Data Triangulation 
   2.4. Assumptions for the Study  

3. Executive Summary
   3.1. Market Outlook
   3.2. Segment Outlook
   3.3. Competitive Insights

4. Implantable Pulse Generator Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Implantable Pulse Generator Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Implantable Pulse Generator Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Implantable Pulse Generator Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Implantable cardiac pacemakers
   7.2. Implantable defibrillators
   7.3. Cochlear implants
   7.4. Implantable nerve stimulators (FES)
        7.4.1. Limb function stimulation
        7.4.2. Bladder stimulators
        7.4.3. Sphincter stimulators
        7.4.4. Diaphragm stimulators
        7.4.5. Analgesia
   7.5. Implantable infusion pumps
   7.6. Implantable active monitoring devices

8. Implantable Pulse Generator Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Neurovascular Diseases
   8.2. Cardiovascular Diseases
   8.3. Orthopedic

9. Implantable Pulse Generator Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)  
   9.1. Hospitals
   9.2. Ambulatory Surgical Centers
   9.3. Home Care Settings
   9.4. Clinics

10. North America Implantable Pulse Generator Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    10.1. Introduction
    10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          10.2.1. U.S.A
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Implantable Pulse Generator Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    11.1. Introduction
    11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          11.2.1. Brazil
          11.2.2. Venezuela
          11.2.3. Argentina
          11.2.4. Rest of Latin America
    11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Implantable Pulse Generator Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    12.1. Introduction
    12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          12.2.1. Germany
          12.2.2. U.K         
          12.2.3. France
          12.2.4. Italy
          12.2.5. Spain
          12.2.6. Russia
          12.2.7. Poland
          12.2.8. Rest of Europe
    12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Implantable Pulse Generator Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    13.1. Introduction
    13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          13.2.1. Japan
          13.2.2. China
          13.2.3. India
          13.2.4. Australia and New Zealand
          13.2.5. ASEAN
          13.2.6. Rest of Asia Pacific
    13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. GCC
          14.2.2. Israel
          14.2.3. South Africa
          14.2.4. Rest of MEA
    14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape   
    15.1. Global Landscape - Key Players, Revenue and Presence
    15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    15.3. Global Emerging Companies
    15.4. North America - Market Share Analysis and Key Regional Players
    15.5. Europe - Market Share Analysis and Key Regional Players
    15.6. Asia Pacific - Market Share Analysis and Key Regional Players
    15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    16.1. Medtronic, Inc.
          16.1.1. Company Overview
          16.1.2. Product Portfolio
          16.1.3. SWOT Analysis
          16.1.4. Financial Overview
          16.1.5. Strategic Overview
    16.2. Boston Scientific Corporation
          16.2.1. Company Overview
          16.2.2. Product Portfolio
          16.2.3. SWOT Analysis
          16.2.4. Financial Overview
          16.2.5. Strategic Overview 
    16.3. St. Jude Medical, Inc.
          16.3.1. Company Overview
          16.3.2. Product Portfolio
          16.3.3. SWOT Analysis
          16.3.4. Financial Overview
          16.3.5. Strategic Overview
    16.4. Synapse Biomedical, Inc.
          16.4.1. Company Overview
          16.4.2. Product Portfolio
          16.4.3. SWOT Analysis
          16.4.4. Financial Overview
          16.4.5. Strategic Overview
    16.5. Nevro Corporation
          16.5.1. Company Overview
          16.5.2. Product Portfolio
          16.5.3. SWOT Analysis
          16.5.4. Financial Overview
          16.5.5. Strategic Overview          
    16.6. Neurosigma, Inc.
          16.6.1. Company Overview
          16.6.2. Product Portfolio
          16.6.3. SWOT Analysis
          16.6.4. Financial Overview
          16.6.5. Strategic Overview     
    16.7. Neuropace, Inc.
          16.7.1. Company Overview
          16.7.2. Product Portfolio
          16.7.3. SWOT Analysis
          16.7.4. Financial Overview
          16.7.5. Strategic Overview
    16.8. Cyberonics, Inc.
          16.8.1. Company Overview
          16.8.2. Product Portfolio
          16.8.3. SWOT Analysis
          16.8.4. Financial Overview
          16.8.5. Strategic Overview 
    16.9. BioControl Medical
          16.9.1. Company Overview
          16.9.2. Product Portfolio
          16.9.3. SWOT Analysis
          16.9.4. Financial Overview
          16.9.5. Strategic Overview 

17. Pre and Post COVID-19 Impact
    17.1. Positive influence on the healthcare industry
    17.2. The financial disruption of the manufacturing sector
    17.3. Impact of COVID-19 on emerging companies
    17.4. Significant mandates in the regulations initiated by healthcare administrations
    17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client

Tables

Figures